Heightened production of inflammatory cytokines, recruitment of Th17 cells, and alterations in RANKL and osteoprotegerin (OPG) signaling could represent proposed mechanisms linking COVID-19 to osteoporosis and bone loss [174,175]. The gene discussed is TNFRSF11B; the disease is osteoporosis.